Extra Than 2 Years Into the Pandemic, the FDA Considers Novavax


For essentially the most up-to-date information and details about the coronavirus pandemic, go to the WHO and CDC web sites.

What’s taking place

The FDA is anticipated to authorize Novavax, a brand new COVID-19 vaccine, although it is nonetheless beneath evaluation.

Why it issues

Novavax would be the first protein-based vaccine for COVID-19 out there within the US, although the expertise has been round for many years. Whereas this kind of vaccine has some benefits within the pandemic, it additionally has distinctive challenges.

What’s subsequent

The FDA and CDC might want to resolve how, or if, the US will use Novavax.

With the nation’s eyes on the pending availability of COVID-19 vaccines for kids beneath 5, most individuals have both acquired (or chosen to not obtain) the COVID-19 vaccines and booster doses out there to them. (For those who’re 50 and up, you are eligible for two boosters or a complete of 4 photographs.) 

However a committee of scientists and different consultants that advise the US Meals and Drug Administration final week endorsed Novavax, a protein-based COVID-19 vaccine, for authorization. If the FDA offers it the inexperienced gentle, it will be the fourth COVID-19 vaccine available on the market within the US, and the primary to make use of a extra conventional, protein-based vaccine expertise towards the coronavirus. 

So, why now? Greater than two years into the pandemic, a majority of Individuals (about 67%) are totally vaccinated towards COVID-19, and lots of have added a booster dose or two. These hesitant or against vaccination appear to be persevering with these stances, based on a ballot from the Kaiser Household Basis. The proportion of American adults who answered the ballot who stated they might “undoubtedly not” get a COVID-19 vaccine ranged from 15% in December 2020 to 17% April 2022.

Novavax had a contract with the federal authorities by way of Operation Warp Pace, however has skilled manufacturing issues which have hindered a possible emergency use authorization. Along with inspecting extra information on how Novavax fares towards the omicron variant, the FDA might want to log out on the corporate’s manufacturing earlier than authorizing the vaccine. 

Nonetheless, some scientists are hopeful that Novavax might someday be used as a booster dose together with different vaccines, and that its major collection might fill a necessity for a extra conventional and doubtlessly equally efficient COVID-19 vaccine. It is also already out there in different nations, together with Canada and Australia, beneath the identify Nuvaxovid.

“It is good to have a vaccine on board like Novavax as a result of it is another choice for people who might need contraindications to the opposite vaccine platforms,” Ross Kedl, a professor of immunology and microbiology on the College of Colorado Anschutz Medical Campus, stated in an e-mail. “Some have allergic reactions or extra uncommon considerations like blood clots.”

The Johnson & Johnson COVID-19 vaccine remains to be approved within the US, however use of it has been restricted due to a uncommon however critical danger of blood clots. This leaves Pfizer’s and Moderna’s vaccines as the 2 at the moment advisable choices for many adults.

Authorizing Novavax additionally opens the door for it for use as a booster dose or a part of a mix-and-match method with different COVID-19 vaccines. 

This is what to know.

Woman points to a Band-Aid on her arm after getting a shot.

VioletaStoimenova/Getty Photographs

What’s Novavax? How is it totally different?

Novavax is a COVID-19 vaccine that makes use of a extra conventional protein-based expertise, in contrast to the opposite vaccines at the moment out there within the US: Pfizer-BioNTech and Moderna use mRNA expertise, and Johnson & Johnson is a viral-vector vaccine. 

Within the Novavax vaccine, a purified protein of the virus is blended with what’s known as an adjuvant — components that “get up the immune response and inform it to take this goal severely,” Kedl stated.

Dr. Glenn Wortmann, an infectious illness specialist with MedStar Well being, stated the final method of most vaccines is to make use of a protein base.

“Particularly, Novavax is similar to the hepatitis B vaccine that is given,” which most of us obtain as kids, Wortmann stated. Some vaccines for influenza, shingles and different illnesses use the same expertise.

Whereas it gives another choice, nevertheless, the jury could also be out on whether or not Novavax gives superior immunity to Pfizer’s and Moderna’s vaccines. 

“Immunologically talking, for my part it does not likely deliver an terrible lot by itself to the desk that isn’t already well-addressed by the mRNA vaccines,” Kedl stated. 

Nonetheless, it’s simpler to retailer and ship than mRNA vaccines, he stated. This can be a bonus when vaccinating harder-to-reach communities the place protecting finicky vaccines cool within the fridge could also be troublesome. However Novavax has critical disadvantages in relation to manufacturing, Kedl stated, as a result of it is not low cost for the corporate to provide and purify the proteins. 

“mRNA vaccines skip that step as a result of they flip every particular person into their very own vaccine producer,” he stated. mRNA vaccines work by instructing our cells to make the protein themselves that can set off an immune response.

Because of this, mRNA vaccines are simpler to regulate than Novavax when a brand new variant comes alongside, Kedl stated. 

“The mRNA platform is way extra modifiable than what Novavax does,” he stated. “Each time a brand new variant vaccine must be made, Novavax goes to must do a number of work within the lab to determine which modifications will nonetheless enable a superb protein to be made and purified at mass portions.”

Multiple vials of COVID-19 vaccine against a light blue background.

Yulia Reznikov/Getty Photographs

How efficient is Novavax?

Printed outcomes from a trial discovered that Novavax was greater than 90% efficient towards symptomatic COVID-19, and 100% efficient towards extreme illness and loss of life. However importantly, that trial was performed earlier than the omicron or delta variants had been broadly circulating. Each the delta and omicron variants — together with omicron subvariants like BA.2, BA.2.12.1 and BA.4 — are extra contagious and evade some immunity from vaccines and prior an infection.

Actual-world information evaluating the effectiveness of Novavax to different vaccines would not exist but. Per the World Well being Group, “It’s not possible to match vaccines face to face as a result of totally different approaches taken in designing the respective research.” 

When will Novavax be out there? 

The FDA nonetheless must authorize the first collection (the primary set of photographs, not the booster doses). Whereas it sometimes accepts its advisory committee’s advice, the company must evaluation extra information. 

As soon as it does, a committee of consultants for the Facilities for Illness Management and Prevention will vote whether or not to advocate Novavax, and for whom, after which the CDC’s director will log out the advice.

The FDA’s advisory committee is scheduled to fulfill for a public assembly on June 28 to debate future COVID-19 vaccine formulation — together with for the possible fall or winter COVID-19 surge. 

As soon as approved and advisable, it is unclear how out there, precisely, Novavax will probably be in contrast with Moderna’s and Pfizer’s vaccines, that are stocked at pharmacies, clinics and docs’ places of work nationwide. The US authorities had initially deliberate to buy 110 million doses of the vaccine, The New York Instances reviews, however the US has a adequate provide of COVID-19 vaccines for major doses and booster photographs. 

How will the US pay for Novavax? 

Whereas COVID-19 vaccines have been free and out there to all Individuals, latest funding stalled in Congress and federal officers have warned we’re operating out of cash for COVID-19 exams, vaccines, remedies and associated spending. Some companies for Individuals with out medical insurance have already expired. 

Nonetheless, it’s possible COVID-19 vaccines will stay free, not less than for some time. Cash for COVID-19 testing and protecting gear is being moved round to cowl the prices of vaccines and therapy for the autumn, The New York Instances reviews. 

Can Novavax be used as a booster? 

The FDA is contemplating the authorization of Novavax as a major collection (the primary two doses). If the FDA offers it the inexperienced gentle, it could very nicely grow to be another choice within the US booster catalog. Final fall, the FDA signed off on the mix-and-match method to the approved COVID-19 boosters, or a heterologous booster dose.

As soon as there’s information on utilizing a vaccine like Novavax with mRNA vaccines, “There could also be folks that acquired three or 4 of the mRNA vaccines and is likely to be fascinated about attempting a unique vaccine as a part of a mix-and-match technique,” Wortmann stated. 

“I believe that the true benefit of the Novavax vaccine is to the sphere extra broadly,” Kedl equally stated. “As a result of it now has another vaccine platform to combine and match with the opposite vaccines.”

The knowledge contained on this article is for instructional and informational functions solely and isn’t supposed as well being or medical recommendation. All the time seek the advice of a doctor or different certified well being supplier relating to any questions you will have a couple of medical situation or well being goals.


Supply hyperlink